News | January 06, 2022
ENTOD Pharmaceuticals set to launch Molentod
It is the generic version of molnupiravir
It is the generic version of molnupiravir
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
Aim of the virtual conference is to facilitate Indian Pharma Industry adopt Green & Sustainable Chemistry as a tool to enhance Economic & Environmental Competitiveness
Adbry is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022
It will be marketed under the brand name Molunamax
The product is expected to be available in a week’s time
DCGI approved the drug based on the review of clinical data
The company has developed the API in house at its R&D center in Hyderabad
Flattish volume growth and subdued new launches were key factors for last month
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
Subscribe To Our Newsletter & Stay Updated
